Oh, good lowered. A "doctor" shareholder soliciting other "doctor" shareholders on a social media stock board to put their patients up to try this drug is the most absurd thing I think I've seen on the OTC. Any "doctor" soliciting such or any "doctor" that would do it has had their medical judgment severely compromised by their stock portfolio, and there is no question about that whatsoever. They need to let their patients know they cannot be objective and recommend they seek treatment from others who are.
News 
Market Data 
Discover 
AI
